NasdaqCM - Nasdaq Real Time Price USD

Nephros, Inc. (NEPH)

4.1100
+0.2400
+(6.20%)
As of 10:23:00 AM EDT. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 4.88M
Earnings 558k

Q2'24

Q3'24

Q4'24

Q1'25

0
1M
2M
3M
4M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

4.50
4.75 Average
4.1100 Current
5.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2221
Avg. Estimate -0.03-0.0100.01
Low Estimate -0.03-0.02-0.010.01
High Estimate -0.02-0.010.020.01
Year Ago EPS -0.030.020.010

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2221
Avg. Estimate 3.6M3.75M16.01M18.24M
Low Estimate 3.5M3.6M15.51M18.24M
High Estimate 3.7M3.9M16.5M18.24M
Year Ago Sales 3.25M3.52M14.16M16.01M
Sales Growth (year/est) 10.73%6.59%13.02%13.94%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. -0.01-0.02-0.01-0
EPS Actual -0.030.020.030.05
Difference -0.020.040.050.06
Surprise % -100.00%200.00%300.00%1,100.00%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.03-0.0100.01
7 Days Ago 00.010.020.04
30 Days Ago 00.010.020.04
60 Days Ago 00.010.020.04
90 Days Ago 0.010.010.020.07

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days 21--1
Down Last 30 Days 21--1

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
NEPH 16.67%-175.00%-50.00%100.00%
S&P 500 13.13%2.38%7.54%14.08%

Upgrades & Downgrades

Reiterates Benchmark: Speculative Buy to Speculative Buy 11/12/2024
Reiterates Benchmark: Speculative Buy to Speculative Buy 5/15/2024
Upgrade Benchmark: Hold to Speculative Buy 3/8/2024
Initiated B. Riley Securities: Buy 1/26/2021
Initiated Benchmark: Speculative Buy 10/24/2019
Initiated Maxim Group: Buy 10/4/2019

Related Tickers